Vikramjeet Singh v. Union of India and Ors.
Case brief
What is this about?
Rare disease writ petition; infant patient with Spinal Muscular Atrophy (SMA) Type-I confirmed by SNM1 Gene Analysis/MLPA; syrup Risdiplam as disease-modifying therapy; National Policy for Rare Diseases 2021 financial assistance capped at ₹50 lakhs (sufficient for two years of medicines); written consent in prescribed proforma; PGIMER Chandigarh medical evaluation; Institute Rare Diseases Committee; National Rare Diseases Cell; Delhi HC judgment Master Arnesh Shaw v. Union of India and Anr., W.P. (C) 5315/2020 (no maximum cap on rare-disease financial assistance) under Supreme Court scrutiny, operation stayed by order dated 09.12.2024 in SLP (C) No.28777/2024; direction for periodic release of funds upon petitioner's consent; liberty to seek other reliefs; CWP-1658-2025 (O&M); decided 17.03.2025 by Kuldeep Tiwari J.
What did the court decide?
Direction upon the respondent(s) concerned to forthwith release, periodically, the requisite funds for the patient's medical care and medicines as and when the petitioner furnishes his written consent; petitioner left at liberty to claim any other apposite relief(s) before the competent authority/forum.